Re: Neoadjuvant PD-L1 plus CTLA-4 Blockade in Patients with Cisplatin-ineligible Operable High-risk Urothelial Carcinoma.
Sarah M H Einerhand
,
Jeroen van Dorp
,
Michiel S van der Heijden
,
Bas W G van Rhijn
More about this publication
European urology
Volume
83
Issue nr.
1
Pages
91-92
Publication date
01-01-2023
Full text links
Publisher website (DOI)
10.1016/j.eururo.2022.09.024
Europe PubMed Central
36210214
Pubmed
36210214